Jalabert, Maud http://orcid.org/0000-0002-1597-3150
Ferkal, Salah
Souberbielle, Jean-Claude
Sbidian, Emilie
Mageau, Arthur
Eymard, Florent
Le Corvoisier, Philippe
Allanore, Laurence
Chevalier, Xavier
Wolkenstein, Pierre
Guignard, Sandra
Funding for this research was provided by:
Association Neurofibromatoses et von recklinghausen (45500euros)
Article History
Received: 9 December 2020
Accepted: 8 January 2021
First Online: 8 February 2021
Compliance with Ethical Standards
:
: Maud Jalabert, Salah Ferkal, Arthur Mageau, Laurence Allanore, Philippe Le Corvoisier, Florent Eymard, Emilie Sbidian declare that they have no conflict of interest. Xavier Chevalier declare he have conflict of interest with IBSA, Flexion Therapics, Pfizer, Sanofi and Nordic Pharma. Pierre Wolkenstein declare he have conflict of interest with AstraZeneca, Springworks, Laboratoire d’Uriage, Pierre Fabre Dermatologie. J.C. Souberbielle declare he have conflict of interest with DiaSorin, Roche diagnostics, Mylan, MSD, Lily, Effik, Iprad Pharma, Yoplait.
: All animal procedures were approved by the national French ethical committee.